Unknown

Dataset Information

0

Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People.


ABSTRACT: Our goal in this study was to determine whether or not anserine/carnosine supplementation (ACS) is capable of preserving cognitive function of elderly people. In a double-blind randomized controlled trial, volunteers were randomly assigned to an ACS or placebo group at a 1:1 ratio. The ACS group took 1.0?g of an anserine/carnosine (3:1) formula daily for 3 months. Participants were evaluated by psychological tests before and after the 3-month supplementation period. Thirty-nine healthy elderly volunteers (60-78 years old) completed the follow-up tests. Among the tests, delayed recall verbal memory assessed by the Wechsler Memory Scale-Logical Memory showed significant preservation in the ACS group, compared to the placebo group (p?=?0.0128). Blood analysis revealed a decreased secretion of inflammatory cytokines, including CCL-2 and IL-8, in the ACS group. MRI analysis using arterial spin labeling showed a suppression in the age-related decline in brain blood flow in the posterior cingulate cortex area in the ACS group, compared to the placebo group (p?=?0.0248). In another randomized controlled trial, delayed recall verbal memory showed significant preservation in the ACS group, compared to the placebo group (p?=?0.0202). These results collectively suggest that ACS may preserve verbal episodic memory and brain perfusion in elderly people, although further study is needed.

SUBMITTER: Hisatsune T 

PROVIDER: S-EPMC4927867 | biostudies-other | 2016

REPOSITORIES: biostudies-other

altmetric image

Publications

Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People.

Hisatsune Tatsuhiro T   Kaneko Jun J   Kurashige Hiroki H   Cao Yuan Y   Satsu Hideo H   Totsuka Mamoru M   Katakura Yoshinori Y   Imabayashi Etsuko E   Matsuda Hiroshi H  

Journal of Alzheimer's disease : JAD 20160101 1


Our goal in this study was to determine whether or not anserine/carnosine supplementation (ACS) is capable of preserving cognitive function of elderly people. In a double-blind randomized controlled trial, volunteers were randomly assigned to an ACS or placebo group at a 1:1 ratio. The ACS group took 1.0 g of an anserine/carnosine (3:1) formula daily for 3 months. Participants were evaluated by psychological tests before and after the 3-month supplementation period. Thirty-nine healthy elderly v  ...[more]

Similar Datasets

| S-EPMC7528151 | biostudies-literature
| S-EPMC4089385 | biostudies-other
| S-EPMC2997155 | biostudies-literature
| S-EPMC4868921 | biostudies-literature
| S-EPMC7527554 | biostudies-literature
| S-EPMC4189412 | biostudies-literature
| S-EPMC5653294 | biostudies-literature
| S-EPMC6234960 | biostudies-literature
| S-EPMC6240385 | biostudies-literature
| S-EPMC6248922 | biostudies-literature